Playback speed
10 seconds
Potential for Recurrent Monkeypox Outbreaks, Nirmatrelvir/Ritonavir Receiving FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19, Efficacy and Safety of Antimicrobial Stewardship Prospective Audit and Feedback in Patients Hospitalized with COVID-19
9 views
August 2, 2023
Login to view comments.
Click here to Login